US slashes vaccine schedule; Every drug approval from 2025; argenx’s new CEO; and morenews2026-01-10T11:00:00+00:00January 10th, 2026|Endpoints News|
Joel Habener, Whose Research Led to Weight-Loss Drugs, Dies at 88news2026-01-09T22:54:21+00:00January 9th, 2026|The New York Times|
Eikon Therapeutics files for IPO, testing biotech rallynews2026-01-09T22:14:35+00:00January 9th, 2026|Endpoints News|
Asia-US container rates jump on pre-Lunar New Year demand surge, carrier hikesnews2026-01-09T22:01:00+00:00January 9th, 2026|Independent Commodity Intelligence Services (ICIS)|
NYMEX: US gas futures lower as 10-15 day cold risk alleviated toward seasonal normsnews2026-01-09T21:54:00+00:00January 9th, 2026|Independent Commodity Intelligence Services (ICIS)|
CRUDE SUMMARY: Crude prices climb as civil unrest in Iran fuels risk premiumnews2026-01-09T20:26:00+00:00January 9th, 2026|Independent Commodity Intelligence Services (ICIS)|
How Merck plans to set a buffer for Keytruda’s patent cliffnews2026-01-09T20:03:19+00:00January 9th, 2026|Endpoints News|
Plant status: TPC Group issues FM on US BD amid operational, feedstock issuesnews2026-01-09T19:33:00+00:00January 9th, 2026|Independent Commodity Intelligence Services (ICIS)|
US consumer sentiment ticks up for second monthnews2026-01-09T18:51:00+00:00January 9th, 2026|Independent Commodity Intelligence Services (ICIS)|
Aktis’ 25% IPO bounce builds hope for 2026’s public offeringsnews2026-01-09T18:44:41+00:00January 9th, 2026|Endpoints News|
